U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
AMIVANTAMAB
0JSR7Z0NB6
US Approved Rx (2021)
First approved in 2021
General
Names
9
Classification
1
Identifiers
8
Subunits
4
Related Substances
1
AMIVANTAMAB
0JSR7Z0NB6
US Approved Rx (2021)
First approved in 2021
General
Approval Year
2021
460
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
AMIVANTAMAB
Official Name
English
JNJ-61186372
Preferred Name
English
IMMUNOGLOBULIN G1 (413-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL JNJ-61186372 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-61186372 .KAPPA.-CHAIN, (234->228'),(237->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (411-A
Common Name
English
Amivantamab [WHO-DD]
Common Name
English
CNTO-4424
Code
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Bispecific Antibody
NCI_THESAURUS
C1454
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
0JSR7Z0NB6
PRIMARY
NCI_THESAURUS
C124993
PRIMARY
SMS_ID
100000177630
PRIMARY
WIKIPEDIA
Amivantamab
PRIMARY
RXCUI
2549199
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
0JSR7Z0NB6
AMIVANTAMAB
